Literature DB >> 28838665

Infectious and Sporadic Prion Diseases.

Richard Knight1.   

Abstract

Prion diseases are progressive fatal encephalopathies characterized by a neurodegenerative pathology, the tissue deposition of abnormally folded prion protein and, in general, potential transmissibility. Creutzfeldt-Jakob disease (CJD) is the commonest human prion disease and occurs in three principal forms: sporadic (idiopathic), acquired (infectious), and inherited (genetic). This chapter concerns the sporadic and acquired forms. Sporadic CJD occurs worldwide and affects mainly the middle aged and elderly. There are recognized genetic risk factors-most importantly the PRNP-129 polymorphism. The acquired forms of CJD consist of iatrogenic CJD (accidental transmission of CJD via medical or surgical procedures) and variant CJD (vJCD) (which originated as a zoonosis via bovine spongiform encephalopathy (BSE)-contamination of human food). The main causes of iatrogenic CJD are cadaveric-derived human growth hormone treatment and dura mater surgical grafts. The PRNP-129 polymorphism has important effects on iatrogenic infection, including overall susceptibility and incubation period. vCJD, resulting from dietary exposure to BSE, has affected mostly the United Kingdom, followed by France. All tested cases were originally PRNP-129MM, although two MV cases have been identified recently (one possible; one definite). vCJD has been secondarily transmitted via blood transfusion and a blood product. There is continuing concern over secondary transmission since there is evidence-from lymphoreticular tissue studies-of extensive subclinical infection in the UK general population, although a further recent study has caused uncertainty over the significance of the previous studies. While definitive diagnosis of CJD is pathological, recent developments in protein amplification and detection have led to significantly better clinical diagnosis.
© 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CJD; Creutzfeldt–Jakob disease; Iatrogenic CJD; Sporadic CJD; Variant CJD

Mesh:

Year:  2017        PMID: 28838665     DOI: 10.1016/bs.pmbts.2017.06.010

Source DB:  PubMed          Journal:  Prog Mol Biol Transl Sci        ISSN: 1877-1173            Impact factor:   3.622


  10 in total

1.  A single amino acid residue in bank vole prion protein drives permissiveness to Nor98/atypical scrapie and the emergence of multiple strain variants.

Authors:  Laura Pirisinu; Michele Angelo Di Bari; Claudia D'Agostino; Ilaria Vanni; Geraldina Riccardi; Stefano Marcon; Gabriele Vaccari; Barbara Chiappini; Sylvie L Benestad; Umberto Agrimi; Romolo Nonno
Journal:  PLoS Pathog       Date:  2022-06-22       Impact factor: 7.464

2.  Difference of geographic distributions of the Chinese patients with prion diseases in the permanent resident places and referring places.

Authors:  Kang Xiao; Ming-Fan Pang; Yue-Qiao Zhao; Li-Ping Gao; Yue-Zhang Wu; Yuan Wang; Qi Shi; Xiao-Ping Dong
Journal:  Prion       Date:  2022-12       Impact factor: 2.547

3.  D159 and S167 are protective residues in the prion protein from dog and horse, two prion-resistant animals.

Authors:  Jonatan Sanchez-Garcia; Pedro Fernandez-Funez
Journal:  Neurobiol Dis       Date:  2018-07-24       Impact factor: 5.996

4.  Creutzfeldt-Jakob Disease after Dental Procedure along with the Initial Manifestations of Psychiatric Disorder: A Case Report.

Authors:  Rahim Badrfam; Ahmad Ali Noorbala; Zahra Vahabi; Atefeh Zandifar
Journal:  Iran J Psychiatry       Date:  2021-01

5.  Sporadic Creutzfeldt-Jakob disease prion infection of human cerebral organoids.

Authors:  Bradley R Groveman; Simote T Foliaki; Christina D Orru; Gianluigi Zanusso; James A Carroll; Brent Race; Cathryn L Haigh
Journal:  Acta Neuropathol Commun       Date:  2019-06-14       Impact factor: 7.801

6.  Combining autophagy stimulators and cellulose ethers for therapy against prion disease.

Authors:  Basant A Abdulrahman; Waqas Tahir; Katsumi Doh-Ura; Sabine Gilch; Hermann M Schatzl
Journal:  Prion       Date:  2019-01       Impact factor: 3.931

7.  Preclinical transmission of prions by blood transfusion is influenced by donor genotype and route of infection.

Authors:  M Khalid F Salamat; A Richard Alejo Blanco; Sandra McCutcheon; Kyle B C Tan; Paula Stewart; Helen Brown; Allister Smith; Christopher de Wolf; Martin H Groschup; Dietmar Becher; Olivier Andréoletti; Marc Turner; Jean C Manson; E Fiona Houston
Journal:  PLoS Pathog       Date:  2021-02-18       Impact factor: 6.823

8.  Studies in bank voles reveal strain differences between chronic wasting disease prions from Norway and North America.

Authors:  Romolo Nonno; Michele A Di Bari; Laura Pirisinu; Claudia D'Agostino; Ilaria Vanni; Barbara Chiappini; Stefano Marcon; Geraldina Riccardi; Linh Tran; Turid Vikøren; Jørn Våge; Knut Madslien; Gordon Mitchell; Glenn C Telling; Sylvie L Benestad; Umberto Agrimi
Journal:  Proc Natl Acad Sci U S A       Date:  2020-11-23       Impact factor: 11.205

Review 9.  The Translational Benefits of Sheep as Large Animal Models of Human Neurological Disorders.

Authors:  Samantha J Murray; Nadia L Mitchell
Journal:  Front Vet Sci       Date:  2022-02-15

10.  Transmission characteristics of heterozygous cases of Creutzfeldt-Jakob disease with variable abnormal prion protein allotypes.

Authors:  Anne Ward; Jason R Hollister; Kristin McNally; Diane L Ritchie; Gianluigi Zanusso; Suzette A Priola
Journal:  Acta Neuropathol Commun       Date:  2020-06-09       Impact factor: 7.801

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.